Overview

Nicotine Delivery Rate and Its Abuse Potential: Impact of Menthol

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
A placebo-controlled study to enroll male and female tobacco smokers menthol (n=35) and non-menthol (n=35) who will participate in five experimental sessions. subjects will be given an IV infusion of either saline or 1 mg nicotine at rapid, moderate or slow infusion rates (nicotine at 0.24,0.096, 0.048 and 0.024, mcg per kg body weight per sec).
Phase:
Early Phase 1
Details
Lead Sponsor:
Yale University
Treatments:
Menthol
Nicotine